- Home
- SLS vs HTBK Comparison
SLS vs HTBK Comparison
Compare SLS & HTBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLS | HTBK |
|---|---|---|
| Founded | 2012 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 706.7M | 739.7M |
| IPO Year | 2007 | 1998 |
Fundamental Metrics
Financial Performance| Metric | SLS | HTBK |
|---|---|---|
| Price | $4.95 | $13.45 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 6 |
| Target Price | $10.00 | ★ $12.88 |
| AVG Volume (30 Days) | ★ 4.2M | 655.6K |
| Earning Date | 05-11-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 3.87% |
| EPS Growth | ★ 50.00 | 18.18 |
| EPS | N/A | ★ 0.78 |
| Revenue | N/A | ★ $3,688,000.00 |
| Revenue This Year | N/A | $7.80 |
| Revenue Next Year | $110.98 | $5.51 |
| P/E Ratio | ★ N/A | $17.24 |
| Revenue Growth | N/A | ★ 3.57 |
| 52 Week Low | $1.39 | $8.95 |
| 52 Week High | $6.14 | $13.83 |
Technical Indicators
Market Signals| Indicator | SLS | HTBK |
|---|---|---|
| Relative Strength Index (RSI) | 52.38 | 64.54 |
| Support Level | $4.70 | $11.85 |
| Resistance Level | $5.28 | $13.65 |
| Average True Range (ATR) | 0.27 | 0.31 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 57.02 | 81.90 |
Price Performance
Historical ComparisonAbout SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About HTBK Heritage Commerce Corp
Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. Majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.